Hypertonic glucose vs insulin–dextrose to prevent hypoglycaemia following treatment for hyperkalaemia (HIGH-K): protocol for a double-blind randomized controlled trial

Background Hyperkalaemia is a life-threatening electrolyte abnormality commonly managed with intravenous insulin–dextrose therapy (IDT). Although effective, IDT frequently causes hypoglycaemia, particularly in patients without diabetes. Glucose-only therapy, which leverages endogenous insulin produc...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Samuel Ford, Adam La Caze, Ian Coombes, Angela Hills, Jaimi Greenslade, Julian Williams
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Taylor & Francis Group 2026-12-01
Ráidu:	Annals of Medicine
Fáttát:	Emergency department endogenous insulin hyperkalaemia hypoglycaemia hypertonic glucose solutions randomised controlled Trials
Liŋkkat:	https://www.tandfonline.com/doi/10.1080/07853890.2026.2701477
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!